Skip to content
Home
About
Scientific publications
Media coverege
Other resources
Contact
Home
About
Scientific publications
Media coverege
Other resources
Contact
Knowledge center
We share our knowledge
Scientific
publications
A novel platform for attenuating immune hyperactivity using EXO-CD24 in COVID-19 and beyond
Read more ⇢
Insights into CD24 and Exosome Physiology and Potential Role in View of Recent Advances in COVID-19 Therapeutics: A Narrative Review. Life, 2022
Read more ⇢
The Big Potential of Small Particles: Lipid-Based Nanoparticles and Exosomes in Vaccination. Vaccines, 2022
Read more ⇢
Inhaled Exosomes Genetically Manipulated to Overexpress CD24 (EXO-CD24) as a Compassionate Use in Severe ARDS Patients. Biomedicine, 2023
Read more ⇢
The safety and potential efficacy of exosomes overexpressing CD24 (EXO‑CD24) in mild‑moderate COVID‑19 related ARDS. Respiratory research, 2024
Read more ⇢
Inhaled CD24-Enriched Exosomes (EXO-CD24) as a Novel Immune Modulator in Respiratory Disease. IJMS, 2024
Read more ⇢
Media coverage
"Magični metak" - lek koji Srbija planira da nabavi u borbi protiv kovida
Read More ⇢
Interest grows in three experimental COVID-19 treatments
Read More ⇢
Israeli drug holds promise of stopping fatal Covid-19 immune response
Read More ⇢
El medicamento 'de Fierabrás' israelí que curaría el covid en 5 días
Read More ⇢
A fin de año estaría en uso revolucionario remedio israelí para Covid-19
Read More ⇢
O tratamento israelita que promete revolucionar o combate à covid-19
Read More ⇢
Lek iz Izraela navodno zaustavlja kovid za pet dana
Read More ⇢
COVID: 90% of patients treated with new Israeli drug discharged in 5 days
Read More ⇢
Show More
Other resources
Conference
Conference
